WHO Model List of Essential Medicines – 23rd List (2023), section 6.1.1 Intestinal anthelmintics (2023)

Government Record · World Health Organization (WHO/MHP/HPS/EML/2023.02) · 2023

World Health Organization (WHO/MHP/HPS/EML/2023.02), 2023: The WHO essential medicines list places mebendazole 100 mg and 500 mg chewable tablets on the core list of intestinal anthelmintics, alongside albendazole, ivermectin, levamisole, niclosamide, praziquantel and pyrantel. It also lists mebendazole 100 mg and 500 mg on the complementary list.

6.1.1 Intestinal anthelminthics albendazole Tablet (chewable, scored): 400 mg. ivermectin Tablet: 3 mg. levamisole Tablet: 50 mg; 150 mg (as hydrochloride). mebendazole Tablet (chewable): 100 mg; 500 mg.

p. 7

World Health Organization (WHO/MHP/HPS/EML/2023.02), 2023: The WHO essential medicines list places mebendazole 100 mg and 500 mg chewable tablets on the core list of intestinal anthelmintics, alongside albendazole, ivermectin, levamisole, niclosamide, praziquantel and pyrantel. It also lists mebendazole 100 mg and 500 mg on the complementary list. WHO normative list document (record-field transcription of the list entries, hence the list-style excerpt). PDF pagination: p. 7 is the printed page number on the page. WHO content is published under CC BY-NC-SA 3.0 IGO; recorded as Foreign Government for the copyright_status field because the field has no intergovernmental option. No study data, no funder/conflict statement applicable. The PDF URL above is the direct bitstream used and opened. Study type: regulatory record.